The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Session highlights: integrating cellular therapy in myeloma
Krina Patel
• 26 Aug 2022
Krina Patel, MD, Msc, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of her presentation at the 2022 IMS meeting, which covered several topics, including how to optimize treatment approaches and patient access to CAR-T therapy, patient eligibility for CAR-T, and issues with manufacturing processes. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
